Analystreport

Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations